Thomas Geraghty

PFD Report All Responded Ref: 2024-0362
Date of Report 21 June 2024
Coroner Laura Bradford
Coroner Area East Sussex
Response Deadline est. 23 September 2024
All 1 response received · Deadline: 23 Sep 2024
Response Status
Responses 1 of 1
56-Day Deadline 23 Sep 2024
All responses received
About PFD responses

Organisations named in PFD reports must respond within 56 days explaining what actions they are taking.

Source: Courts and Tribunals Judiciary

Coroner’s Concerns
Mr Geraghty had been prescribed anti-psychotic medication since 2007, which he took on a daily basis. His symptoms responded well to the medication and his mental health was assessed in 2015 as stable. Mr Geraghty informed his family that he felt safe taking his medication and had intended to remain on it for life. In January 2021, Mr Geraghty's GP surgery noted that he had moved out of its catchment area and a letter was sent to him advising him to register with a new surgery closer to his new home address. Mr Geraghty does not appear to have registered with a new surgery and remained a patient of his original surgery. He continued to receive a repeat prescription for his anti-psychotic medication and received his COVID vaccinations and also text messages from the surgery relating to smoking cessation advice up to November 2021. On 4 May 2022, the surgery sent Mr Geraghty a text message to confirm that they were still prescribing his medication and that he needed to provide his new surgery details. No details were provided by Mr Geraghty and he continued to be prescribed his anti-psychotic medication with the last prescription, a two-month supply, issued on 10 November 2022. Mr Geraghty requested a repeat prescription via his usual automated service on 12 January 2023. Mr Geraghty appears to have been deregistered as a patient by the surgery on 16 January 2023 and there does not appear to have been any communication with Mr Geraghty at this time to inform him of the deregistration. Two chaser emails were sent to the surgery by the pharmacy to seek authorisation for the prescription but no response was received and Mr Geraghty, who had not yet registered with another surgery went without his anti-psychotic medication. He was not on any medication at the time of his death and family noted that some of his psychotic symptoms had returned in June 2023. I have a concern that individuals can be removed from the surgery as patients without any scrutiny as to whether the individual may be receiving vital medication (either for a mental health or physical health issue). There does not appear to be any process of review in relation to these patients to ensure that they will continue to receive their medication after they are deregistred from the surgery. This is of particular concern where a patient is deregistered and the surgery has not been provided with details of an individual's new GP. There is a concern that in these circumstances, an individual may be left without access to medication, which could cause or contribute to their death.
Responses
Chelsfield Surgery
13 Aug 2024
Chelsfield Surgery has updated its Removal of Patients Policy, making it a mandatory requirement for the Safeguarding Lead to be consulted before patient deductions. They have also implemented a new administrative review process, circulated updated policies to staff, and commenced an audit of past deductions. AI summary
View full response
Dear HM Coroner I write on behalf of the Chelsfield Surgery in response to your Regulation 28 report dated 21 June 2024. We note the concerns you have raised and write to reassure you of the steps that the Surgery have taken to review how patients are deducted from the list and implement changes in our procedure when patients are removed in the future. Whilst writing, may we correct one matter noted on the Regulation 28 report. It is stated that Patient TG was deregistered as a patient by the surgery on 16 January 2023, which is inaccurate. The records indicate that the deduction request was submitted by the Practice on 28 November 2022 and completed on 29 December 2022. PCSE requested a copy of Patient TG’s medical records on 29 December 2022 and these were then sent on 16 January 2023. The member of the administrative team who dealt with transferring the records also made an entry into the medical consultations page to state that Patient TG had been deducted. This entry is dated 16 January 2023 – but the deduction had already taken effect from 29 December 2022.
1. On 25 July 2024 the practice held a Significant Event Analysis (“SEA”) meeting. The details of Patient TG’s deduction from the list were presented and learning outcomes discussed. These included: a clinician should have been consulted before the deduction was submitted in November 2022, safeguarding considerations ought to have been raised and discussed with safeguarding lead, Patient TG ought to have been sent a further letter informing him of the deduction and Patient TG ought to have received advice about continuing his medication supply.
2. As a practice we have considered, reviewed and updated our Removal of Patients Policy. Before any removal can take place it is now a mandatory requirement for the Safeguarding Lead to be consulted to ensure that all safeguarding concerns have been appropriately addressed. It is also now a mandatory requirement for a patient to receive a written notification when a deduction has taken place.
3. We have also reviewed and updated our Repeat Prescribing Policy. Our Policy now states: (a) In the event of removing a patient, we will ensure that the patient is provided with an adequate supply of medication to last until they register elsewhere, usually a maximum of 2 months’ supply. Chelsfield Surgery

_________________________________________________________________________________________________ (b) We will now write to the patient to explain that this will be the final prescription from the practice and that the patient needs to register elsewhere to ensure continuity of their medication. In circumstances where there are safeguarding concerns, we will continue to prescribe medication until we receive confirmation that the patient has registered with a GP elsewhere. Any decision to then stop prescribing must usually be made by the safeguarding lead, or if they are unavailable then a senior clinician, and be clearly documented. (c) Any deduction that takes place will now be reviewed by the administration team in the immediate period after the deduction. This is a safety net process to ensure that any safeguarding concerns have been discussed and appropriate action taken.
4. The updated policies and learning points arising from the SEA have been circulated by email to all non-clinical staff. A practice meeting is scheduled on 14 August 2024 for all non-clinical staff to attend. The conclusions of the SEA will be disseminated to ensure that all staff learn from this case. We will highlight the updated policies and changes to procedure to ensure that there is no risk of repetition when deducting patients in the future.
5. The Practice Manager is conducting an audit of all deductions which have taken place in the last 3 years. Through this audit we hope to ensure that no other patients have been affected by a deduction and to check if there are any additional learning points which arise.
6. A continuing monthly audit will be undertaken by the Practice Manager for all patients deducted in the future. This audit will ensure that all deductions are appropriate, that any safeguarding concerns have been addressed and that the deduction does not disrupt continuity of care. This results of this audit will be fed into the safeguarding meetings which take place weekly (see below).
7. The Safeguarding Lead GP will now review any patient deductions where there are safeguarding concerns in the weekly safeguarding meeting. These patients will be discussed and checks made to ensure that clinical needs are being met, particularly with respect to prescriptions / access to vital medication. We hope that this will reassure HM Coroner that we have taken her concerns on board and taken steps to review our processes and implement change.
Report Sections
Investigation and Inquest
On 04 July 2023 I commenced an investigation into the death of Thomas Joseph GERAGHTY aged 39. The investigation concluded at the end of the inquest on 21 June 2024. The conclusion of the inquest was: Suicide
Circumstances of the Death
On the morning of 28 June 2023 Thomas Joseph Geraghty entered the sea from the beach at Eastbourne. He was not witnessed entering the water. At around 11:45, Mr Geraghty’s body was seen floating by a nearby lifeguard and he was recovered to the beach. Resuscitation was attempted however it was sadly unsuccessful and death was confirmed.
Related Inquiry Recommendations

Public inquiry recommendations addressing similar themes

Pre-1996 Transfusion Testing
Infected Blood Inquiry
Incomplete GP Patient Data Transfer
New Patient Registration Screening
Infected Blood Inquiry
Incomplete GP Patient Data Transfer
Patient Transfer Protocol
Hyponatraemia Inquiry
Incomplete GP Patient Data Transfer
Service change continuity plans
Vale of Leven Inquiry
Care and discharge planning
Continuing responsibility for care
Mid Staffs Inquiry
Care and discharge planning
Follow up of patients
Mid Staffs Inquiry
Care and discharge planning

Data sourced from Courts and Tribunals Judiciary under the Open Government Licence.